Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

Publication | Closed Access

DOI

1.1K

Citations

References

2005

Year

Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff, Henry A. Nasrallah, Sonia M. Davis, Lisa Sullivan, Herbert Y. Meltzer, John Hsiao, T. Scott Stroup, Jeffrey A. Lieberman

Schizophrenia Research

Intervention EffectivenessMetabolic SyndromeMetabolic DisorderPsychiatryPsychotic DisorderNhanes IiiGlobal HealthPsychotropic MedicationClinical EpidemiologyPsychopharmacologySchizophreniaSocial SciencesMedicinePsychopathology